Ann: Prescient Receives $2.4 Million R&D Tax Rebate, page-6

Agree re PTX100.

I follow a few US biotechs ( and a few Aussie biotechs - RCE, BIO IMU, MAP).

The embers of potential success due to the convergence of AI and medical research is getting the first signs of oxygen. Some may not be aware that Palantir's CTO has become Chairman of Ginkgo Bioworks. IMO, the best AI Company with cross ties to Bio-engineering - that is exciting.

Whether PTX is able to ride the upcoming swing to the upside, who knows, but I am not sure anyone (especially me !) can really see what's coming in the next 5 to 10 years. Transformational for many both healthwise and financially.